Sign in
CompletedNo phase

Metabolomics Analysis of Acute Kidney Injury and Delirium After Cardiac Surgery

Key facts

Who runs it
Xijing Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
120 people enrolled
Started
20 Jul 2024
Ended
31 Dec 2024
Type of study
Observational, 4 groups
Treatments tested
  • Serum metabolic profile
Record updated
6 April 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • 18 years old and above
  • Patients undergone elective cardiac surgery
  • History of serum creatinine test within 7 days before surgery
  • Provide venous blood samples
  • Voluntarily participate and sign an informed consent form

Who cannot take part

  • Other related diseases that have been previously confirmed to have cognitive impairment, or records of using drugs targeting cognitive impairment during the onset period
  • Individuals with a history of brain tumors, traumatic brain injury, brain parasitic diseases, and other diseases that may cause cognitive impairment
  • Individuals with a history of alcohol and drug addiction
  • Patients treated with chronic peritoneum or hemodialysis, prior kidney transplantation, preoperative serum creatinine level>4.5mg/dL (400 μ mol/L) or end-stage renal disease (defined as glomerular filtration rate<15ml · min-1 · 1.73m-2)
  • Individuals with severe speech, visual, hearing, or mental impairments that affect cognitive scale assessment
  • Pregnant and lactating women

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Clinical evidence suggests that renal injury leads to changes in the structure of the cerebral cortex in patients, suggesting the existence of the renal brain axis. Therefore, some scholars have proposed that AKI may be an important cause of secondary injuries such as delirium. Approximately 60% of AKI patients in clinical practice experience delirium.Although the underlying mechanism associated with acute renal injury and delirium is still unclear, it has been recognized that it increases incidence rate and mortality, prolongs hospital stay, and accelerates long-term cognitive decline. The investigators assume that the serum metabolic profiles of patients with delirium and AKI after cardiac surgery, with delirium only, with AKI only, and without delirium or AKI after surgery can be compared separately to explore the mechanisms of complications and the interaction mechanisms between organ damage after extracorporeal circulation cardiac surgery, and to identify metabolic markers specific to complications, identify patients with increased susceptibility, and provide reference for early diagnosis of complications and basis for early intervention.

The 4 groups in the trial

  • AKI group

    Patients developed AKI after cardiac surgery

    Treatment: Serum metabolic profile

  • Delirium group

    Patients developed delirium 5 days after cardiac surgery

    Treatment: Serum metabolic profile

  • AKI and delirium group

    Patients developed AKI and delirium after cardiac surgery

    Treatment: Serum metabolic profile

  • Control group

    Patients didn't develope AKI or delirium after cardiac surgery

    Treatment: Serum metabolic profile

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Metabolomics Analysis of Acute Kidney Injury and Delirium After Cardiac Surgery: Single Center, Prospective, Observational Study
Record updated
6 April 2025